DrugPatentWatch Database Preview
Profile for China Patent: 103948913
US Patent Family Members and Approved Drugs for China Patent: 103948913
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | May 18, 2031 | Sanofi Us Services | TOUJEO MAX SOLOSTAR | insulin glargine recombinant |
➤ Sign Up | May 18, 2031 | Sanofi Us Services | TOUJEO SOLOSTAR | insulin glargine recombinant |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |